Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04680533 · ClinicalTrials.gov registry record · Phase 1

Wireless TENS for Peripheral Edema (Lower Limb Swelling)

A Phase 1 study, sponsored by University of Rochester.

Terminated
Registry status
Phase 1
Development phase
3
Enrollment target

NCT04680533: Clinical Trial Phase 1 study, sponsored by University of Rochester.

NCT04680533 is a Phase 1 study that was terminated before completion, run by University of Rochester. The registered enrollment target is 3 participants, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (95% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04680533, a Phase 1 study, was terminated before completion, sponsored by University of Rochester.

TERMINATED
Registry status
Phase 1
Development phase
3 participants
Enrollment target

Study Summary

This study is single center, subject will receive a wireless TENS device. All subjects will be allowed to keep the commercially-available device for use after the study. The primary goal is to test the feasibility of the study design and secondary is to test the preliminary efficacy of the TENS.

Primary Outcome

Swelling and symptoms associated with edema will be recorded in the Edema Symptom Diary using a verbal rating scale of swelling in the lower limbs and feet using the anchors "none", "a little bit", "quite a bit" "a lot", or "very much", which converts to a 1 to 5 measurable scale, with \[1 = none, 5 = very much\]. The scores per each symptom per day will be summed and averaged over 7 days. The higher the score the worse the health outcome. The range of scores the participant can achieve per day

Interventions

  • DEVICE Transcutaneous Electrical Nerve Stimulation (TENS)

Trial Details

FieldValue
Enrollment Target 3 participants
Start Date 2021-06-28
Est. Completion 2024-02-22
Phase Phase 1
University of Rochester

636 total trials

Why NCT04680533 stopped before completion

NCT04680533 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 3 participants, a relatively small participant target, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (95% lower).

The record links to 0 conditions, and to 1 intervention - of which Transcutaneous Electrical Nerve Stimulation (TENS) is the first listed.

NCT04680533 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT04680533 about?

NCT04680533 is a clinical study titled "Wireless TENS for Peripheral Edema (Lower Limb Swelling)". This study is single center, subject will receive a wireless TENS device. All subjects will be allowed to keep the commercially-available device for use after the study. The primary goal is to test the feasibility of the study design and secondary is to test the preliminary efficacy of the TENS.

What is the current status of trial NCT04680533?

This trial is currently terminated. It is a Phase 1 study. The enrollment target is 3 participants. The study started on 2021-06-28. Estimated completion is 2024-02-22.

What interventions are being tested in trial NCT04680533?

The interventions under investigation include: Transcutaneous Electrical Nerve Stimulation (TENS) (DEVICE).

Who is sponsoring clinical trial NCT04680533?

This trial is sponsored by University of Rochester, which has 636 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT04680533's enrollment target sits among peer trials

3 1999th of 2000 higher than 1 of 2,000 other Phase 1 trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04680533, the US trial registry maintained by the National Library of Medicine. NCT04680533 (small enrollment · none site footprint · terminated) retrieved and formatted by PlainTrial, see methodology.